SEC-sourced researchBeta
LUNG
Pulmonx Corp
Company comparison ↗
Data passport
- CIK
- 0001127537
- Exchange
- Nasdaq
- Business activity
- — · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Sep 3, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 83,789,000.0000 | Mar 10, 2026 |
| December 2025 | 90,497,000.0000 | Mar 10, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 90,497,000.0000 | -54,003,000.0000 | -32,376,000.0000 | 129,291,000.0000 | 75,175,000.0000 | Mar 10, 2026 |
| December 2024 | 83,789,000.0000 | -56,394,000.0000 | -31,537,000.0000 | 162,850,000.0000 | 77,041,000.0000 | Mar 10, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $90.5M | December 2025 | Mar 10, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $83.79M | December 2024 | Mar 10, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$54M | December 2025 | Mar 10, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$32.38M | December 2025 | Mar 10, 2026 | 10-K |
| Total assetsAssets | $129.29M | December 2025 | Mar 10, 2026 | 10-K |
| Total liabilitiesLiabilities | $75.18M | December 2025 | Mar 10, 2026 | 10-K |